MKS Instruments (MKSI) Tops Q1 EPS by 26c; offers guidance

MKS Instruments (NASDAQ: MKSI) reported Q1 EPS of $2.30, $0.26 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

MKS Instruments sees Q2 2026 EPS of $2.90 plus or minus $0.30, versus the consensus of $2.38. MKS Instruments sees Q2 2026 revenue of $1.2 billion plus or minus $40 million, versus the consensus of $1.086 billion.

For earnings history and earnings-related data on MKS Instruments (MKSI) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results